Lördag 21 December | 19:33:36 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2024-02-20 - Bokslutskommuniké 2023
2023-11-07 - Kvartalsrapport 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-04-26 - X-dag ordinarie utdelning BIOS 0.00 SEK
2023-04-25 - Årsstämma
2023-04-25 - Kvartalsrapport 2023-Q1
2023-02-22 - Bokslutskommuniké 2022
2022-11-15 - Kvartalsrapport 2022-Q3
2022-09-19 - Extra Bolagsstämma 2022
2022-08-31 - Kvartalsrapport 2022-Q2
2022-05-04 - X-dag ordinarie utdelning BIOS 0.00 SEK
2022-05-03 - Årsstämma
2022-05-03 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-09 - Kvartalsrapport 2021-Q3
2021-08-12 - Kvartalsrapport 2021-Q2
2021-05-04 - Kvartalsrapport 2021-Q1
2021-04-20 - X-dag ordinarie utdelning BIOS 0.00 SEK
2021-04-19 - Årsstämma
2021-02-23 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-05-08 - X-dag ordinarie utdelning BIOS 0.00 SEK
2020-05-07 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-21 - Bokslutskommuniké 2019
2019-11-05 - Kvartalsrapport 2019-Q3
2019-09-10 - Extra Bolagsstämma 2019
2019-08-13 - Kvartalsrapport 2019-Q2
2019-05-10 - X-dag ordinarie utdelning BIOS 0.00 SEK
2019-05-06 - Årsstämma
2019-05-06 - Kvartalsrapport 2019-Q1
2019-02-19 - Bokslutskommuniké 2018
2018-11-06 - Kvartalsrapport 2018-Q3
2018-10-02 - Extra Bolagsstämma 2018
2018-08-24 - Kvartalsrapport 2018-Q2
2018-05-03 - X-dag ordinarie utdelning BIOS 0.00 SEK
2018-05-02 - Årsstämma
2018-05-02 - Kvartalsrapport 2018-Q1
2018-02-26 - Bokslutskommuniké 2017
2017-11-16 - Kvartalsrapport 2017-Q3
2017-08-17 - Kvartalsrapport 2017-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorIndustri
IndustriIndustriprodukter
Bioservo Technologies är ett teknikbolag inriktade mot hälsovårdssektorn. Bolaget utvecklar robotteknologi anpassat för personer som lider utav nedsatt muskelstyrka. Teknologin baseras på den framtagna SEM-teknologin (Soft Extra Muscle), som används för att hantera patientens uthållighet. Ett exempel är bolagets servohandske som är anpassad för personer med nedsatt funktion i händerna. Bolaget grundades 2006 och har sitt huvudkontor i Kista.
2023-08-01 08:30:00

Bioservo Technologies receives an order for 25 Ironhand systems at an order value of 1.2 MSEK from Rhino Tool House for sale on the US market.

[image]

The successful implementation of more than 60 Ironhand systems at the Waupaca Foundry, which has resulted in a significant reduction in hand injuries, has generated increased interest among companies in the foundry and other grip-intensive industries. To meet this increased interest, Rhino Tool House is placing an order for 25 Ironhand systems for delivery in the third quarter.

For more information, please contact
Petter Bäckgren, CEO, Bioservo Technologies AB
Phone: +468 21 17 10
petter.backgren@bioservo.com
 

Mikael Wester, Marketing Director, Bioservo Technologies AB
Phone: +468 21 17 10
mikael.wester@bioservo.com

This information is such that Bioservo Technologies AB (publ) is obliged to publish in accordance with EU Regulation on Market Abuse (MAR). The information was submitted for publication through the agency of above contact persons for publication on August 1, 2023 at 08:30 a.m. CET
 

About Bioservo Technologies
Bioservo Technologies AB (publ) is a world-leading company in wearable muscle-strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve workers' health and quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB is the company's Certified Adviser on Nasdaq First North.
For more information, please visit www.bioservo.com